The Real-Time PCR Market Size was valued at USD 5.2 billion in 2022 and expected to reach USD 8.07 billion by 2030, and grow at a CAGR of 5.65% over the forecast period 2023-2030.
The Real-Time PCR (qPCR) market is experiencing significant growth and is expected to continue its upward trajectory in the coming years. Real-Time PCR, also known as quantitative PCR, is a powerful molecular biology technique used for the detection and quantification of DNA or RNA molecules in real-time.
One of the key factors driving the growth of the qPCR market is the increasing demand for accurate and rapid diagnostic solutions. Real-Time PCR offers several advantages over traditional PCR methods, including faster turnaround time, higher sensitivity, and specificity. These features make it an ideal choice for various applications such as infectious disease diagnosis, genetic testing, cancer research, and drug discovery.
Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2573
The COVID-19 pandemic has further accelerated the adoption of Real-Time PCR technology. The need for rapid and accurate testing to detect SARS-CoV-2 has led to a surge in demand for qPCR-based diagnostic kits. Many companies have ramped up their production capacities to meet this increased demand, leading to a boost in the overall qPCR market As the world continues to grapple with the ongoing COVID-19 pandemic, the importance of Real-Time PCR technology in infectious disease diagnosis has become even more evident. The ability to quickly and accurately detect SARS-CoV-2 has not only helped in controlling the spread of the virus but has also paved the way for effective contact tracing and targeted interventions. Moreover, the increased demand for qPCR-based diagnostic kits has not only led to a boost in the overall qPCR market but has also spurred innovation in the field. Companies are investing in research and development to improve the sensitivity and specificity of these kits, making them even more reliable in detecting not just COVID-19 but also other infectious diseases. Furthermore, the widespread adoption of Real-Time PCR technology has opened up new avenues for genetic testing, cancer research, and drug discovery. The ability to analyze genetic material with high precision and speed has revolutionized these fields, enabling scientists and researchers to make significant advancements in understanding diseases, developing personalized treatments, and discovering new therapeutic targets. In conclusion, the COVID-19 pandemic has not only accelerated the adoption of Real-Time PCR technology but has also highlighted its immense potential in various applications. The advancements made in this field during these challenging times will continue to benefit healthcare, research, and diagnostic industries long after the pandemic is over.
KEY MARKET SEGMENTS
By End User
- Hospitals &Diagnostic Centers
- Research Laboratories & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Clinical Research Organizations
- Forensic Laboratories
- Reagents & Consumables
- Software & Services
Major Players Listed in the Report are as Follows:
BD, Bio-Rad Laboratories, Inc., Hoffmann-La Roche Ltd, QIAGEN, ABL SA Group, Agilent Technologies, Inc., Analytik Jena AG, Fluidigm Corporation, Lumex Instruments, Primerdesign Ltd. and Other Players
SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.
We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.
Akash Anand – Head of Business Development & Strategy,
Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)